- 专利标题： Bladder cancer biomarker proteins
-
申请号： US16065663申请日： 2016-12-23
-
公开(公告)号： US11536724B2公开(公告)日： 2022-12-27
- 发明人: Jerome Garin , Christophe Masselon , Antonia Vlahou , Manousos Makrydakis , Ieronimos Zoidakis , Bruno Domon , Elodie Duriez , Aurelie Kamoun , Francois Radvanyi , Yves Allory , Nuria Malats Riera , Mirari Marquez Cid , Magali Court
- 申请人： Polyquant GmbH , COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES , BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS , LUXEMBOURG INSTITUTE OF HEALTH , INSTITUT CURIE , ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS , FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III, CNIO
- 申请人地址： DE Bad Abbach; FR Paris; GR Athens; LU Luxembourg; FR Paris; FR Paris; ES Madrid
- 专利权人： Polyquant GmbH,COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES,BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS,LUXEMBOURG INSTITUTE OF HEALTH,INSTITUT CURIE,ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS,FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III, CNIO
- 当前专利权人： Polyquant GmbH,COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES,BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS,LUXEMBOURG INSTITUTE OF HEALTH,INSTITUT CURIE,ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS,FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III, CNIO
- 当前专利权人地址： DE Bad Abbach; FR Paris; GR Athens; LU Luxembourg; FR Paris; FR Paris; ES Madrid
- 代理机构： Viksnins Harris Padys Malen LLP
- 优先权： EP15202453 20151223
- 国际申请： PCT/EP2016/082558 WO 20161223
- 国际公布： WO2017/109171 WO 20170629
- 主分类号： G01N31/00
- IPC分类号： G01N31/00 ; G01N33/53 ; G01N33/68 ; C07K7/08 ; G01N33/574 ; C07K14/54 ; C07K16/30
摘要：
The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.
公开/授权文献
- US20180372754A1 BLADDER CANCER BIOMARKER PROTEINS 公开/授权日：2018-12-27
信息查询
